Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Wilson

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Neurology|June 13, 2024
Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and ChildrenJames A Varley, Dimitrios Champsas, Timothy Prossor, et al.
Plos One|February 12, 2016
A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer ModelCorey Saba, Melissa Paoloni, Christina Mazcko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 28, 2026
Loss of serotonergic function in carriers of PRKN mutations: a [<sup>11</sup>C]DASB PET studyEdoardo Rosario de Natale, Heather Wilson, Joji P Verghese, et al.
Plos One|April 30, 2015
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional StudyCheryl A London, Heather L Gardner, Tamra Mathie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine LymphomaJenna H Burton, Christina Mazcko, Amy LeBlanc, et al.
Neurology|August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple SclerosisSarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Acta Neuropathologica|July 20, 2021
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated stateVeena Kochat, Ayush T Raman, Sharon M Landers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2Nicola J Mason, Laura Selmic, Audrey Ruple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 DogsAmy K LeBlanc, Christina N Mazcko, Aswini Cherukuri, et al.
Nature Immunology|December 18, 2019
High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variationLucie Abeler-Dörner, Adam G Laing, Anna Lorenc, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Neurology|June 13, 2024
Validation of the 2023 International Diagnostic Criteria for MOGAD in a Selected Cohort of Adults and ChildrenJames A Varley, Dimitrios Champsas, Timothy Prossor, et al.
Plos One|February 12, 2016
A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer ModelCorey Saba, Melissa Paoloni, Christina Mazcko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 28, 2026
Loss of serotonergic function in carriers of PRKN mutations: a [<sup>11</sup>C]DASB PET studyEdoardo Rosario de Natale, Heather Wilson, Joji P Verghese, et al.
Plos One|April 30, 2015
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional StudyCheryl A London, Heather L Gardner, Tamra Mathie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine LymphomaJenna H Burton, Christina Mazcko, Amy LeBlanc, et al.
Neurology|August 7, 2025
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple SclerosisSarmad Al-Araji, Marcello Moccia, Ashwani Jha, et al.
Acta Neuropathologica|July 20, 2021
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated stateVeena Kochat, Ayush T Raman, Sharon M Landers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2Nicola J Mason, Laura Selmic, Audrey Ruple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 DogsAmy K LeBlanc, Christina N Mazcko, Aswini Cherukuri, et al.
Nature Immunology|December 18, 2019
High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variationLucie Abeler-Dörner, Adam G Laing, Anna Lorenc, et al.
Pageof 12